Single cell nuclear sequencing and spatial transcriptome sequencing were used to observe the evolution of fetal neural abnormalities

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300070041

Enrollment

Unknown

Registered

2023-03-31

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any of various disorders of fetal neural development

Interventions

normal group:NA

disease group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Pregnant women can carry out normal language communication and communication; (2) Couples who have the intention of abortion or can not continue pregnancy because of serious pregnancy diseases or severe fetal malformations. ; (3) Voluntarily accept exchange interviews; ? All pregnant women and their family members signed informed consent and volunteered to participate in the clinical study.

Exclusion criteria

Exclusion criteria: ? pregnant women with communication disorders; ? Pregnant women or their family members refuse.

Design outcomes

Primary

Measure	Time frame
Cell type, gene expression difference, etc;	—

Countries

China

Contacts

Public ContactLiulin-Xiong

Affiliated Hospital of Zunyi Medical University

499465010@qq.com+86 18227648803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026